Sabine Mueller, MD, PhD

Quick facts

Phase 2 pipeline

• ONC206

Phase 1 pipeline

• K27M peptide
• Modified Measles Virus
• Modified Measles Virus Lumbar Puncture
• Panobinostat Nanoparticle Formulation MTX110

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sabine Mueller, MD, PhD portfolio CI brief
• Sabine Mueller, MD, PhD pipeline updates RSS

Related

• Sector hub: All tracked pharma companies